Actively Recruiting
Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)
Led by Heinrich-Heine University, Duesseldorf · Updated on 2024-10-03
200
Participants Needed
1
Research Sites
21 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the PSA-Cap study is to test the comparability of measurements of total PSA in serum from venipuncture and in serum from capillary blood using anonymized diagnostic blood samples from patients. Furthermore, a stability test of the samples is carried out after storage at room temperature for 24, 72/96 and 168 hours. Particular attention is paid to the comparability of the measurement results and the influence of the transportation time.
CONDITIONS
Official Title
Determination of Prostate-specific Antigen in Capillary Blood (PSA-Cap)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men aged from 45 to 70 years
- Informed consent for PSA measurement for prostate cancer screening
You will not qualify if you...
- Patients unable to give consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Klinik für Urologie, Universitätsklinikum Düsseldorf
Düsseldorf, North Rhine-Westphalia, Germany, 40225
Actively Recruiting
Research Team
M
Martin Wallisch
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here